Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)

The study introduced a novel nomenclature and classification system for female functional androgenization (FA), including conditions like polycystic ovary syndrome and non-classic congenital adrenal hyperplasia. It was a retrospective case-control study involving 126 FA patients and controls, categorized into five groups based on specific symptoms and variables such as acne, hirsutism, androgenetic alopecia, BMI, testosterone levels, and insulin response. The classification aimed to improve diagnosis and treatment by identifying individual dysfunctions and disorders, thus enhancing risk assessment and scientific methodology in clinical studies. The study found significant differences in hormone levels and metabolic markers among the groups, with P-values ranging from 0.05 to 0.0001, indicating the effectiveness of the classification system in distinguishing between different FA entities.